N Meng, F Fu, J Sun, P Feng, Y Luo, Y Wu… - … Imaging in Medicine …, 2022 - ncbi.nlm.nih.gov
Background Noninvasive assessment of programmed death-ligand 1 (PD-L1) expression status in non-small cell lung cancer (NSCLC) is necessary. This study arm to investigate the …
X Wang, YY Cao, Y Jiang, M Jia, G Tian… - Journal of Magnetic …, 2024 - Wiley Online Library
Background The amide proton transfer‐weighted (APTw) imaging for kidney diseases is important. However, the breathing patterns on APTw imaging remains unexplored. Purpose …
X Qi, Q Wang, Z Shen, M Duan, X Liu… - … imaging in medicine …, 2024 - ncbi.nlm.nih.gov
Background With the continuous innovation of magnetic resonance imaging (MRI) hardware and software technology, amide proton transfer-weighted (APTw) imaging has been applied …
P Xie, Q Huang, L Zheng, J Li, S Fu, P Zhu, X Pan… - European …, 2024 - Springer
Objective To explore the sub-regional histogram features of amide proton transfer-weighted (APTw) MRI, compared with those of diffusion-weighted imaging (DWI), in predicting the …
X Wu, T Su, Y Chen, Z Xu, X Wang, G Hu, Y Wang… - Cancers, 2024 - mdpi.com
Simple Summary Amide proton transfer weighted (APTw) imaging is a contrast-free molecular imaging method based on the chemical exchange saturation transfer (CEST) …
Y Wang, L Wang, H Huang, J Ma, L Lin, L Liu… - Frontiers in …, 2023 - frontiersin.org
Purpose To assess the usefulness of amide proton transfer-weighted (APTw) imaging in the differentiation of parotid gland tumors. Materials and methods Patients with parotid gland …